Shots: Early results from TemPredict study conducted at the University of California unveils that the Oura Ring’s continuous temperature monitoring could detect fevers before patients began to experience symptoms, suggesting […]readmore
Tags : Symptoms
Shots: The company discontinues P-II proof POC study of Lu AF11167 in patients with schizophrenia, who are experiencing persistent negative symptoms (NCT03793712). The P-II study evaluated two doses of Lu […]readmore
Shots: Cipla’s Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation is first device-based metered dose inhaler receives approval in the US which will further strengthen Cipla’s footprints in the US The first […]readmore
Shots: PRA Health Science reports the availability of the COVID-19 Monitoring Program, a three-tiered mobile-app driven program tracking the individuals’ physical and psychological symptoms of COVID-19 The app monitors an […]readmore
DigiHealth
Regulatory
Voluntis’ Oleena Digital Application Receives FDA’s Marketing Approval to Self-Manage
Shots: The US FDA has completed its regulatory review of Oleena software which is a Class II medical device facilitating oncology-related symptoms management and remote patient monitoring Oleena is embedded […]readmore